Study Start-Up

ForeSiteTM Study Start-Up

Working together for a strong start.

Start-Up Tools

As clinical development becomes more complex, an issue in even one aspect of start-up can delay an entire study. In fact, today, more than half of all trials are delayed because of regulatory requirements, difficulty balancing patient and protocol needs, or the complexity of managing multiple sites.

Our ForeSiteTM approach pulls everyone onto the same team, with centralized oversight and real-time analytics so you can collaborate seamlessly and make decisions more easily. In fact, according to recent research, our partners were able to get from final protocol to initiating their first site 12% more quickly than with other service providers.

We do this with:

  • An award-winning Country Allocation Tool (CAT) that helps develop consensus on which, and how many, sites to engage to simplify the site selection process
  • Our Site Alliance Network consisting of approximately 500 member organizations, as well as several site management organizations (SMOs), together providing access to more than 17,000 investigators worldwide
  • A scoring process that delivers consistent, objective assessment of sites against key criteria
  • Critical Path Managers (CPMs), dedicated study start-up experts who track and manage progress against plans to proactively identify and mitigate risk
  • Weekly Panel Review meetings to ensure prioritization and momentum
  • A process that eliminates standard causes of delays and rework through:
    • Excellent project management capability
    • Experience-based understanding of site relationships
    • Deep understanding of the regulatory process

Site Selection

Our site selection tools equip you fully with solutions that combine big data with the day-to-day realities of patients. With predictive analytics, we help identify sites to give you the greatest shot at development success and deliver data in an easy-to-understand format.

We are always available for a conversation.